NOVARTIS AG-SPONSORED ADR (NVS)
US66987V1098 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.974B -11.87% | 43.375B -1.36% | 46.66B 7.57% | 51.343B 10.04% | 53.678B 4.55% | 54.793B 2.08% | 54.381B -0.75% | 55.946B 2.88% | 55.56B -0.69% | 52.846B -4.88% | 51.341B -2.85% | |
| EBITDA YoY % growth | 17.076B -9.09% | 17.387B 1.82% | 20.919B 20.31% | 20.45B -2.24% | 21.932B 7.25% | 22.611B 3.10% | 23.524B 4.04% | 24.515B 4.21% | 25.33B 3.32% | 23.66B -6.59% | 22.155B -6.36% | |
| EBIT YoY % growth | 10.963B -11.01% | 10.206B -6.91% | 12.642B 23.87% | 17.507B 38.48% | 18.986B 8.45% | 20.015B 5.42% | 21.56B 7.72% | 22.482B 4.28% | 22.633B 0.67% | 21.087B -6.83% | 18.41B -12.70% | |
| Operating Margin | 24.93% | 23.53% | 27.09% | 34.10% | 35.37% | 36.53% | 39.65% | 40.19% | 40.74% | 39.90% | 35.86% | |
| EPS YoY % growth | 6.36 8.82% | 6.18 -2.70% | 6.97 12.75% | 7.83 12.24% | 8.44 7.90% | 9.02 6.79% | 9.21 2.13% | 9.62 4.47% | 9.42 -2.09% | 8.76 -7.03% | 7.51 -14.29% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.90 22.34% | 2.19 20.25% | 2.31 15.41% | 2.20 5.52% | 1.88 -1.04% |
| Revenue Q2Q % growth | 13.127B 14.92% | 12.913B 9.16% | 13.352B 6.71% | 13.102B 2.18% | 12.495B -4.81% |
| EBITDA Q2Q % growth | 3.964B -64.81% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 4.447B 48.88% | 5.263B 40.72% | 5.426B 29.65% | 5.141B 18.29% | 4.274B -3.89% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.09 12.93% | 2.01 | 0.08 | 3.78% |
| Q2 2024 Q2Q % growth | 2.00 8.00% | 1.93 | 0.06 | 3.24% |
| Q1 2024 Q2Q % growth | 1.82 5.61% | 1.73 | 0.09 | 5.40% |
| Q4 2023 Q2Q % growth | 1.55 0.99% | 1.68 | -0.12 | -7.44% |
| Q3 2023 Q2Q % growth | 1.85 15.82% | 1.78 | 0.07 | 3.88% |
| Q2 2023 Q2Q % growth | 1.85 17.31% | 1.75 | 0.10 | 5.73% |
| Q1 2023 Q2Q % growth | 1.73 17.12% | 1.58 | 0.15 | 9.32% |
| Q4 2022 Q2Q % growth | 1.54 8.57% | 1.45 | 0.09 | 6.28% |
| Q3 2022 Q2Q % growth | 1.60 -7.60% | 1.60 | 0.00 | -0.02% |
| Q2 2022 Q2Q % growth | 1.58 -6.02% | 1.54 | 0.03 | 2.08% |
| Q1 2022 Q2Q % growth | 1.48 -3.95% | 1.48 | -0.01 | -0.62% |
| Q4 2021 Q2Q % growth | 1.41 4.48% | 1.46 | -0.05 | -3.12% |
| Q3 2021 Q2Q % growth | 1.73 12.50% | 1.70 | 0.03 | 1.93% |
| Q2 2021 Q2Q % growth | 1.68 22.06% | 1.59 | 0.09 | 5.67% |
| Q1 2021 Q2Q % growth | 1.54 -2.56% | 1.61 | -0.07 | -4.32% |
| Q4 2020 Q2Q % growth | 1.35 1.52% | 1.41 | -0.06 | -4.21% |
| Q3 2020 Q2Q % growth | 1.54 7.80% | 1.50 | 0.04 | 2.60% |
| Q2 2020 Q2Q % growth | 1.37 1.49% | 1.36 | 0.01 | 0.78% |
| Q1 2020 Q2Q % growth | 1.58 28.93% | 1.43 | 0.14 | 9.89% |
| Q4 2019 Q2Q % growth | 1.33 5.60% | 1.34 | -0.01 | -0.40% |
| Q3 2019 Q2Q % growth | 1.42 7.63% | 1.39 | 0.04 | 2.86% |
| Q2 2019 Q2Q % growth | 1.35 3.88% | 1.26 | 0.09 | 7.40% |
| Q1 2019 Q2Q % growth | 1.22 -5.47% | 1.18 | 0.04 | 3.42% |
| Q4 2018 Q2Q % growth | 1.26 | 1.32 | -0.05 | -4.01% |
| Q3 2018 Q2Q % growth | 1.32 | 1.34 | -0.01 | -1.04% |
| Q2 2018 Q2Q % growth | 1.30 | 1.31 | -0.01 | -0.45% |
| Q1 2018 Q2Q % growth | 1.29 | 1.31 | -0.01 | -0.92% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 12.823B 8.84% | 12.994B | -171M | -1.32% |
| Q2 2024 Q2Q % growth | 12.512B -8.15% | 12.61B | -98M | -0.78% |
| Q1 2024 Q2Q % growth | 11.829B -10.44% | 11.709B | 120M | 1.02% |
| Q4 2023 Q2Q % growth | 11.423B -12.14% | 11.996B | -573M | -4.78% |
| Q3 2023 Q2Q % growth | 11.782B -8.25% | 12.001B | -219M | -1.82% |
| Q2 2023 Q2Q % growth | 13.622B 4.10% | 13.518B | 104M | 0.77% |
| Q1 2023 Q2Q % growth | 13.208B 3.07% | 12.877B | 331M | 2.57% |
| Q4 2022 Q2Q % growth | 13.001B -3.85% | 13.285B | -284M | -2.14% |
| Q3 2022 Q2Q % growth | 12.842B -3.93% | 13.106B | -264M | -2.01% |
| Q2 2022 Q2Q % growth | 13.085B -1.57% | 13.109B | -24M | -0.18% |
| Q1 2022 Q2Q % growth | 12.814B 0.95% | 12.942B | -128M | -0.99% |
| Q4 2021 Q2Q % growth | 13.522B 3.78% | 13.616B | -94M | -0.69% |
| Q3 2021 Q2Q % growth | 13.367B 6.61% | 13.285B | 82M | 0.62% |
| Q2 2021 Q2Q % growth | 13.294B 14.39% | 12.773B | 521M | 4.08% |
| Q1 2021 Q2Q % growth | 12.694B -0.11% | 12.771B | -77M | -0.60% |
| Q4 2020 Q2Q % growth | 13.03B 2.47% | 13.147B | -117M | -0.89% |
| Q3 2020 Q2Q % growth | 12.538B 0.45% | 12.818B | -280M | -2.18% |
| Q2 2020 Q2Q % growth | 11.622B -3.34% | 12.13B | -508M | -4.19% |
| Q1 2020 Q2Q % growth | 12.708B 11.45% | 12.249B | 459M | 3.75% |
| Q4 2019 Q2Q % growth | 12.716B 7.07% | 12.517B | 199M | 1.59% |
| Q3 2019 Q2Q % growth | 12.482B 9.90% | 12.065B | 417M | 3.46% |
| Q2 2019 Q2Q % growth | 12.024B 3.36% | 11.752B | 272M | 2.31% |
| Q1 2019 Q2Q % growth | 11.402B 2.26% | 11.601B | -199M | -1.72% |
| Q4 2018 Q2Q % growth | 11.876B | 13.581B | -1.705B | -12.55% |
| Q3 2018 Q2Q % growth | 11.358B | 13.233B | -1.875B | -14.17% |
| Q2 2018 Q2Q % growth | 11.633B | 13.236B | -1.603B | -12.11% |
| Q1 2018 Q2Q % growth | 11.15B | 12.87B | -1.72B | -13.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.27% | 3.06% | 1.27% | 1.65% |
| Revenue | 0% | 1.81% | 0% | 1.08% |